News
Read the latest analysis on ImmunityBio stock: strong Anktiva NMIBC data but slow sales and valuation concerns.
SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the “Company”), a ...
ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of Pb212 alpha radioligand therapies (ARTs), today announced that the U.S. Food and Drug Administration ...
A Westlake Village man living with frontotemporal dementia has something few people with the condition do: the ability to ...
The funding isn't enough for many schools, and disparities exist in urban and small rural districts. Officials are trying to ...
From 2023 to 2024, districts in Connecticut spent, on average, almost a quarter of total expenditures on special education.
Residents are waiting for the government to say how long their drinking water has been contaminated, and what can be done to fix it ...
Fluorescent nanomaterials smaller than 10 nm can disrupt drug-resistant bacteria through multiple mechanisms while enabling ...
Tissue Paper Market for Residential Use to Grow from USD 40.1 Billion in 2024 to USD 72.2 Billion by 2035 Fueled by Hygiene Awareness and Sustainability. WILMINGTON, DE, UNITED ST ...
(Nippon Shinyaku), announced today that the U.S Food & Drug Administration (FDA) has granted Fast Track designation to NS-229, which is being developed for the treatment of the rare disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results